Close

AVEO Oncology's (AVEO) Tivozanib Receives Disappointing News from FDA Oncologic Drugs Advisory Committee

May 2, 2013 12:57 PM EDT Send to a Friend
AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. today reported that the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login